2009-4-29 Beijing Declaration of IANR (Brief)

Beijing Declaration of International Association of Neurorestoratology  (IANR)

-   Version   Beijing   2009   -

Adopted by the 2nd IANR Annual Conference General  Assembly, Beijing,  China, April 26,  2009

1. With rapid development of basic and clinical  advancement on neural restoration, neurorestoratology has become a distinct  discipline within neurosciences.   

2. World wide neurological impairment due to  neurodegeneration and neural injury is a major factor reducing human longevity  and quality of life. Neurorestoratology seeks therapeutic solutions to this  problem.

3. Neurorestoratology is the sub-discipline of  neuroscience that studies neural regeneration, repair and replacement of damaged  components of the nervous system, neuroplasticity, neuroprotection and  neuromodulatory mechanisms of recovery. The goal of neurorestoratology is to  promote recovery of neural function.

4. The research and scope of neurorestoratology cover  causes and treatments of neurotrauma, neurodegeneration, cerebrovascular anoxia  or ischemia, edema, demyelination, sensory and motor disorders, and neuropathic  pain, as well as neural damage resulting from toxic, physical and chemical  factors, immune, infectious, inflammatory, hereditary, congenital,  developmental, and other causes of neural injury. 

5. Neurorestorative therapies include regeneration and  reconstruction of nervous tissues by transplantation of tissue, cells, or  biomaterials and bioengineering, modulation by electro-magnetic stimulation,  pharmaceutical or chemical therapies, and combinations of the above.    

6. Functional recovery is the objective of  neurorestoratology, requiring close integration of neurorestorative and  neurorehabilitative therapies, as well as the practice of clinical and  preventative medicine to minimize complications of neural degeneration and  damage.

7. Neurorestoratology recognizes the importance of small  functional gains that have significant effects on quality of life.  Neurorestoratology is interested in the mechanisms of spontaneous activity and  enhancing this recovery.

8.   Neurorestoratology supports the highest standards for clinical  trials to evaluate the safety and efficacy of its neurorestorative therapies,  the establishment of validated outcome measures, and ethical treatment of  patients.

9.   The International Association for Neurorestoratology will develop  guidelines for neurorestorative therapies, seek and encourage development of new  therapies, promote multi-center collaboration, and will contribute to the  training of people in the field.   

Proposed by: Hongyun Huang (China),  Geoffrey Raisman (UK), Wagih S El Masri (UK), Dajue Wang (UK), Tiansheng Sun  (China), Enzhong Liu (China), Huancong Zuo (China), Changman Zhou (China), Lin  Chen (China), Michael Chopp (USA), Almudena Ramon-Cueto (Spain), Albert Bohbot  (France), Ziad .M. Al Zoubi  (Jordan), Klaus R.H. von Wild (Germany), Robert M. Levy (USA), Eva Sykova  (Czech), Carlos Lima (Portugal), Patricia E. Phelps (USA), Gerson Chadi  (Brazil), Chee-Pin CHEE (Malaysia), Elena Chernykh (Russia), Debora R. Fior  Chadi (Brazil), Krystyna Domanska-Janik (Poland), Foo-Chiang LEE (Malaysia),  Gustavo Moviglia (Argentina), Yoon Ha (Korea), Russell J Andrews (USA), Milan  Dimitrijevic (USA & Slovenia), Paul R. Sanberg (USA), Mrabet. Abdelfattah  (Tunis), Song Jianxing (Singapore), Wise Young (USA)

(Copyright-free for global publication, reprint  and translation of the "Declaration" )